跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AG-QUETIAPINE XR - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AG-QUETIAPINE XR
Authorized
STANDARD
AG-QUETIAPINE XR
angita pharma inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
9b7ee4ae4ed4080d
Company
angita pharma inc.
Type
Standard
Approval Details
Approval Id
9b7ee4ae4ed4080d
Drug Approval Canada Name
AG-QUETIAPINE XR
Product Name
AG-QUETIAPINE XR
Status
Marketed
Status Date
2022-04-27
Original Market Date
2022-04-27
Din
02520559
Drug Class
Human
Dosage Form
Tablet (Extended-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.08.04
Atc Original
N05AH04 QUETIAPINE
Atc Name
n 05 ah 04
Aig Number
0131858003
Company Name
angita pharma inc.
Company Address
1310 Rue Nobel, Boucherville, Quebec, Canada, J4B 5H3
Active Ingredients
QUETIAPINE (QUETIAPINE FUMARATE)
200 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
9b7ee4ae4ed4080d
Type
Standard
Back to Health Canada Approvals